SELECTIVE LASER TRABECULOPLASTY AS A VALUEABLE MODALITY OF TREATMENT IN OPEN ANGLE GLAUCOMA PATIENT Oral Presentation - Observational Study - Ophthalmologist
Article Sidebar
-
Selective laser trabeculoplasty, trabeculoplasty, open angle glaucoma, intraocular pressure
Abstract
Introduction & Objectives
Selective Laser Trabeculoplasty (SLT) has became an established treatment to lower intraocular
pressure (IOP) for open angle glaucoma (OAG) and ocular hypertension. The aim of this study was to
evaluate IOP lowering effect of SLT and correlate its laser parameter to the successful rate in OAG.
Methods
This is a prospective study of seventeen eyes OAG patients in Cicendo Eye Hospital from 1st
November 2022 to 31th December 2022. SLT performed once in OAG with uncontrolled IOP (IOP >
21 mmHg). Outcome measured were IOP at post laser, 1week , 1 month, and 2 months of follow up
after SLT. Successful criteria determined as greater than 20% IOP reduction. Correlation between
setting operational of SLT and primary outcome were measured. Student’s t-test (two-tailed,
dependent) has been used to find the significance of study parameters.
Results
A total 17 eyes underwent SLT. Mean baseline IOP was 21,12 ? 4,0 mmHg. IOP was significantly
decreased from baseline post laser 18,06 ? 3,17 mmHg; at 1 week 17,06 ? 3,25 mmHg; 1 month
15,53 ? 4,52 mmHg; and at 2 month follow up 15,47 ? 4,02 mmHg (p<0,001). The successful rate of
SLT after two months follow up from this study were 76,5% samples (13 eyes). Mean of total laser
energy was 75,6 ? 16,8 mJ. There was correlation between total laser energy with percentage of 1
month IOP reduction (coefficient : 0,470 (p<0,029)).
Conclusion
SLT is effective and safe for reducing IOP in open angle glaucoma patient.
Full text article
References
Gus Gazzard, Evgenia K, David G, Mariam A, Victoria V, Gareth A, Rachael H, Catey B, Neil N, Keith. (2022).Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: SixYear Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension, American Academy Ophthalmology, Volume 130, Issue 2. doi: 10.1016/j.ophtha.2022.09.009
American Academy of Ophthalmology. Basic and Clinical Science Course, Section 10: Glaucoma. 2021. San Francisco.
Allison, K.; Patel, D.; Alabi, O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus 2020, 12, e11686. [CrossRef] [PubMed]
Latina MA, Sibayan SA, Shin DH, et al. (1998). Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 1998;105:2082-8; discussion 2089-90.
Zgry?niak, A., Prze?dziecka-Do?yk, J., Szali?ski, M., & Turno-Kr?cicka, A. (2021). Selective Laser Trabeculoplasty in the Treatment of Ocular Hypertension and Open-Angle Glaucoma: Clinical Review. Journal of Clinical Medicine, 10(15), 3307. doi:10.3390/jcm10153307
SooHoo JR, Seibold LK, Ammar DA, Kahook MY. Ultrastructural Changes in Human Trabecular Meshwork Tissue after Laser Trabeculoplasty. J Ophthalmol. 2015;2015:476138. doi: 10.1155/2015/476138. Epub 2015 May 12. PMID: 26064672; PMCID: PMC4443779. 7. Guo Y, Ioannidou A, Jute P. Selective laser trabeculoplasty: a review of repeatability. Ann Eye Sci 2019;4:20.
Funarunart P, Treesit I. Outcome After Selective Laser Trabeculoplasty for Glaucoma Treatment in a Thai Population. Clin Ophthalmol. 2021;15:1193-1200 https://doi.org/10.2147/OPTH.S300621
Weinand FS, Althen F. Long-term clinical results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma. Eur J Ophthalmol. 2006;16:100e104.
Lee JW, Liu CC, Chan JC, Lai JS. Predictors of success in selective laser trabeculoplasty for Chinese open-angle glaucoma. J Glaucoma. 2014;23:321–325. doi:10.1097/IJG.0000000000000049
Ansari, E. 10-Year Outcomes of First-Line Selective Laser Trabeculoplasty (SLT) for Primary Open-Angle Glaucoma (POAG). Graefes Arch. Clin. Exp. Ophthalmol. Albrecht Graefes Arch. Klin. Exp. Ophthalmol. 2021, 259, 15971604. [CrossRef]
Abe, R.Y.; Maestrini, H.A.; Guedes, G.B.; Nascimento, M.M.; Iguma, C.I.; de Miranda Santos, H.D.; Nasr, M.G.; Lucena-Junior, R.P.; Prata, T.S. Real-World Data from Selective Laser Trabeculoplasty in Brazil. Sci. Rep. 2022, 12, 1923. [CrossRef]
Garg et al. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension
Khawaja, A.P.; Campbell, J.H.; Kirby, N.; Chandwani, H.S.; Keyzor, I.; Parekh, M.; McNaught, A.I.; Vincent, D.; Angela, K.; Nitin, A.; et al. Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom. Ophthalmology 2020, 127, 748–757. [CrossRef] [PubMed] 15. Sarenac T, Be?i? Turkanovi? A, Ferme P, Gra?ner T. A Review of Selective Laser Trabeculoplasty: “The Hype Is Real”. Journal of Clinical Medicine. 2022; 11(13):3879. https://doi.org/10.3390/jcm11133879
Lee . Song J, Lee PP, Epstein DL, et al. High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma. 2005;14:400–408. doi:10.1097/01.ijg.0000176939.43681.c2
Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for firstline treatment of ocular hypertension and glaucoma (light): a multicentre randomised controlled trial. The Lancet 2019;393:1505–16.
Polat, J.; Grantham, L.; Mitchell, K.; Realini, T. Repeatability of selective laser trabeculoplasty. Br. J. Ophthalmol. 2016, 100, 1437–1441. [CrossRef]
Realini T, Shillingford-Ricketts H, Burt D, Balasubramani GK. West Indies Glaucoma Laser Study (WIGLS): 2. Predictors of Selective Laser Trabeculoplasty Efficacy in Afro-Caribbeans with Glaucoma. J Glaucoma. 2018;27:845e848.
Lee JW, Wong MO, Liu CC, Lai JS. Optimal selective laser trabeculoplasty energy for maximal intraocular pressure reduction in open-angle glaucoma. J Glaucoma. 2015 JunJul;24(5):e128-31. doi: 10.1097/IJG.0000000000000215. PMID: 25651204.
Authors
Copyright (c) 2023 DYAH PURWITA TRIANGGADEWI, Sonie Umbara, R Maula Rifada, Elsa Gustianty, Andika Prahasta
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
